Dihydroergotamine (injection): Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Pratik Bahekar (talk | contribs)
nocaptcha
3,696 edits
No edit summary
Pratik Bahekar (talk | contribs)
nocaptcha
3,696 edits
No edit summary
Line 40: Line 40:
==FDA Package Insert==
==FDA Package Insert==


==MIGRANAL (dihydroergotamine mesylate) spray   Normal  0          false  false  false    EN-US  X-NONE  X-NONE                                                                                                                                                                                                                                                                                                                                                            ==
==MIGRANAL (dihydroergotamine mesylate) spray==


'''  [[MIGRANAL (dihydroergotamine mesylate) spray indications and usage|Indications and Usage]]'''
'''  [[MIGRANAL (dihydroergotamine mesylate) spray indications and usage|Indications and Usage]]'''
Line 59: Line 59:
'''| [[MIGRANAL (dihydroergotamine mesylate) spray labels and packages|Labels and Packages]]'''
'''| [[MIGRANAL (dihydroergotamine mesylate) spray labels and packages|Labels and Packages]]'''


==D.H.E. 45 (dihydroergotamine mesylate) injection, solution   Normal  0          false  false  false    EN-US  X-NONE  X-NONE                                                                                                                                                                                                                                                                                                                                                            ==
==D.H.E. 45 (dihydroergotamine mesylate) injection, solution==
'''  [[D.H.E. 45 (dihydroergotamine mesylate) injection, solution indications and usage|Indications and Usage]]'''
'''  [[D.H.E. 45 (dihydroergotamine mesylate) injection, solution indications and usage|Indications and Usage]]'''
'''| [[D.H.E. 45 (dihydroergotamine mesylate) injection, solution dosage and administration|Dosage and Administration]]'''
'''| [[D.H.E. 45 (dihydroergotamine mesylate) injection, solution dosage and administration|Dosage and Administration]]'''

Revision as of 22:45, 11 February 2014

Dihydroergotamine
MIGRANAL (dihydroergotamine mesylate) spray® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Dihydroergotamine
ClinicalTrials.gov
Dihydroergotamine
D.H.E. 45 (dihydroergotamine mesylate) injection, solution® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Dihydroergotamine
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

For patient information about Dihydroergotamine, click here.

Synonyms / Brand Names: MIGRANAL (dihydroergotamine mesylate) spray®, D.H.E. 45®, DIHYDROERGOTAMINE MESYLATE injection®

Overview

Dihydroergotamine (injection)
Clinical data
ATC code
Pharmacokinetic data
Elimination half-life9 hours
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC33H37N5O5
Molar mass583.678 g/mol

Dihydroergotamine is an ergot alkaloid used to treat migraines.

Category

FDA Package Insert

MIGRANAL (dihydroergotamine mesylate) spray

Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages

D.H.E. 45 (dihydroergotamine mesylate) injection, solution

Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages

Mechanism of Action

Dihydroergotamine is an ergot alkaloid used to treat migraines.[1] [1] Normal 0 false false false EN-US X-NONE X-NONE

References

  1. ↑ 1.0 1.1 "MIGRANAL (DIHYDROERGOTAMINE MESYLATE) SPRAY [VALEANT PHARMACEUTICALS INTERNATIONAL]".

Template:Antimigraine preparations

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Dihydroergotamine_(injection)&oldid=942519"